Senior insider sale
CBO & EVP at ULTRAGENYX PHARMACEUTICAL INC. — senior position signals high conviction
$629.0K
12.52K shares
KASSBERG THOMAS RICHARD plans to sell 12.52K shares of ULTRAGENYX PHARMACEUTICAL INC. valued at approximately $629.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
PERFORMANCE SHARES
COMPENSATION
PERFORMANCE SHARES
COMPENSATION
PERFORMANCE SHARES
COMPENSATION
PERFORMANCE SHARES
COMPENSATION
PERFORMANCE SHARES
COMPENSATION
PERFORMANCE SHARES
COMPENSATION
PERFORMANCE SHARES
COMPENSATION
PERFORMANCE SHARES
COMPENSATION
PERFORMANCE SHARES
COMPENSATION
PERFORMANCE SHARES
COMPENSATION
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2024 | PERFORMANCE SHARES COMPENSATION | 717.00 | — |
2/1/2023 | PERFORMANCE SHARES COMPENSATION | 2K | — |
3/1/2022 | PERFORMANCE SHARES COMPENSATION | 2.34K | — |
10/14/2021 | PERFORMANCE SHARES COMPENSATION | 431.00 | — |
5/6/2021 | PERFORMANCE SHARES COMPENSATION | 354.00 | — |
3/1/2021 | PERFORMANCE SHARES COMPENSATION | 3.06K | — |
10/14/2020 | PERFORMANCE SHARES COMPENSATION | 455.00 | — |
5/6/2020 | PERFORMANCE SHARES COMPENSATION | 469.00 | — |
4/19/2020 | PERFORMANCE SHARES COMPENSATION | 468.00 | — |
3/1/2020 | PERFORMANCE SHARES COMPENSATION | 1.22K | — |
| Total | 11.51K | ||
Completed
Units to sell
240.00
Market value
$12.9K
Units to sell
771.00
Market value
$41.4K
Planned — Approximate Date
Units to sell
11.51K
Market value
$574.7K
Units
12.52K
Value
$629.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/4/2024 | 240.00 | $12.9K | — | Completed |
3/4/2024 | 771.00 | $41.4K | — | Completed |
| Planned — Approximate Date | ||||
3/11/2024 | 11.51K | $574.7K | NASDAQ | Planned |
| Total | 12.52K | $629.0K | ||